{"name":"Angela HUTTNER","slug":"angela-huttner","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Ceftazidime± avibactam with fosfomycin","genericName":"Ceftazidime± avibactam with fosfomycin","slug":"ceftazidime-avibactam-with-fosfomycin","indication":"Multidrug-resistant gram-negative bacterial infections, including carbapenem-resistant Enterobacteriaceae (CRE)","status":"phase_3"}]}],"pipeline":[{"name":"Ceftazidime± avibactam with fosfomycin","genericName":"Ceftazidime± avibactam with fosfomycin","slug":"ceftazidime-avibactam-with-fosfomycin","phase":"phase_3","mechanism":"Ceftazidime-avibactam inhibits bacterial cell wall synthesis while avibactam protects against beta-lactamase degradation, and fosfomycin provides additional cell wall disruption through a distinct mechanism.","indications":["Multidrug-resistant gram-negative bacterial infections, including carbapenem-resistant Enterobacteriaceae (CRE)","Complicated urinary tract infections and intra-abdominal infections caused by resistant pathogens"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNNmtfN25mUE5DSjViTWpLTVpVcHlNeG9kOEY0V1dDSkpIUzlQczdidDBfcVA5a21QT3NVYVg3N0Fock13eXVwUnkyM05SY0RRMzNYQUJ0bEtDTUE5MEd5cE96cWg2eEFiMmNCUV9FRjY5cUV1QVh5S01Pa1djd09semNmd24wTHNQNGc?oc=5","date":"2025-07-17","type":"pipeline","source":"IDSA","summary":"Complicated Urinary Tract Infections - IDSA","headline":"Complicated Urinary Tract Infections","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}